Antimicrobial stewardship: English surveillance programme for antimicrobial utilization and resistance (ESPAUR)

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 11, 2013, Pages 2421-2423

  Ashiru Oredope, Diane ^a   Hopkins, Susan ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Antibiotic prescribing; Primary care; Quality measures; Secondary care

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BEHAVIOR CHANGE; CLOSTRIDIUM DIFFICILE INFECTION; DRUG UTILIZATION; ENTEROBACTERIACEAE; GENERAL PRACTITIONER; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; PATIENT SAFETY; PHYSICIAN ATTITUDE; POLICY; PRESCRIPTION; PRIMARY MEDICAL CARE; PROGRAM DEVELOPMENT; SECONDARY HEALTH CARE; UNITED KINGDOM;

ANTIBIOTIC PRESCRIBING; PRIMARY CARE; QUALITY MEASURES; SECONDARY CARE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG PRESCRIPTIONS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; ENGLAND; HUMANS; PROGRAM DEVELOPMENT;

EID: 84886254272     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt363     Document Type: Article

References (18)

1. European Centre for Disease Prevention and Control and the European Medicines Agency. ECDC/EMEA Joint Technical Report. The Bacterial Challenge: Time to React. 2009. http://www.ecdc.europa.eu/en/publications/ Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf (11 August 2013, date last accessed).
2. Smith R, Coast J. The true cost of antimicrobial resistance.BMJ 2013;346: f1493.
3. Boucher HW, Talbot GH, Benjamin DK Jr et al. 10×'20 progress- development of new drugs active against Gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis 2013; 56: 1685-94.
4. Hillier S, Roberts Z, Dunstan F et al. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case- control study. J Antimicrob Chemother 2007; 60: 92-9.
5. Ashiru-Oredope D, Sharland M, Charani E et al. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart-Then Focus. J Antimicrob Chemother 2012; 67 Suppl 1: i51-63.
6. Moore M, McNulty C. European Antibiotic Awareness Day 2012: TARGET antibiotics through guidance, education, and tools. Br J Gen Pract 2012; 62: 621-2.
7. Mason A. New medicines in primary care: a review of influences on general practitioner prescribing. J Clin Pharm Ther 2008; 33: 1-10.
8. Hulscher ME, Grol RP, van der Meer JW. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 2010; 10: 167-75.
9. Charani E, Edwards R, Sevdalis N et al. Behavior change strategies to influence antibiotic prescribing in acute care: a systematic review. Clin Infect Dis 2011; 53: 651-62.
10. Armstrong D, Ogden J. The role of etiquette and experimentation in explaining how doctors change behaviour: a qualitative study. Sociol Health Illn 2006; 28: 951-68.
11. Lewis PJ, Tully MP. Uncomfortable prescribing decisions in hospitals: the impact of teamwork. J R Soc Med 2009; 102: 481-8.
12. Ivers N, Jamtvedt G, Flottorp S et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012; issue 6: CD000259.
13. HealthandSocialCare InformationCentre. 2012. http://www.hscic.gov. uk/catalogue/PUB11291 (15 August 2013, date last accessed).
14. Health Protection Agency (HPA). HCAI and Antimicrobial Point Prevalence Survey-England. http://www.hpa.org.uk/Topics/InfectiousDiseases/ InfectionsAZ/AntimicrobialResistance/HCAIPointPrevalenceSurvey/ (15 August 2013, date last accessed).
15. Hospital Infection Society. The Third Prevalence Survey of Healthcare-Associated Infections in Acute Hospitals. 2006. http://www. neli.org.uk/integratedcrd.nsf/5fbbcc8a843b38108025755b005ea3f0/bc6fc77502e5fdfa80257217004094c3?OpenDocument (15 August 2013, date last accessed).
16. Livermore DM, Hope R, Reynolds R et al. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother 2013; 68: 2667-74.
17. Davies S. Annual Report of the Chief Medical Officer 2011: Volume Two. Infections and the Rise of Antimicrobial Resistance. http://www.dh.gov.uk/health/2013/03/cmo-vol2/ (15 August 2013, date last accessed).
18. Mölstad S, Erntell M, Hanberger H et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 2008; 8: 125-32.